148 related articles for article (PubMed ID: 1649953)
21. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
22. Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A.
Mason AJ; Farnworth PG; Sullivan J
Mol Endocrinol; 1996 Sep; 10(9):1055-65. PubMed ID: 8885240
[TBL] [Abstract][Full Text] [Related]
23. Identification of specific inhibin A-binding proteins on mouse Leydig (TM3) and sertoli (TM4) cell lines.
Harrison CA; Farnworth PG; Chan KL; Stanton PG; Ooi GT; Findlay JK; Robertson DM
Endocrinology; 2001 Apr; 142(4):1393-402. PubMed ID: 11250918
[TBL] [Abstract][Full Text] [Related]
24. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium.
Welt C; Sidis Y; Keutmann H; Schneyer A
Exp Biol Med (Maywood); 2002 Oct; 227(9):724-52. PubMed ID: 12324653
[TBL] [Abstract][Full Text] [Related]
25. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric cell-kinetic analysis by simultaneously staining nuclei with propidium iodide and fluorescein isothiocyanate.
Pollack A
Methods Cell Biol; 1990; 33():315-23. PubMed ID: 1707490
[No Abstract] [Full Text] [Related]
27. Characterization of type II activin receptors. Binding, processing, and phosphorylation.
Mathews LS; Vale WW
J Biol Chem; 1993 Sep; 268(25):19013-8. PubMed ID: 8395525
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous fluorescent labeling of DNA, RNA, and protein.
Crissman HA; Darzynkiewicz Z; Steinkamp JA; Tobey RA
Methods Cell Biol; 1990; 33():305-14. PubMed ID: 1707489
[No Abstract] [Full Text] [Related]
29. [Family of inhibins and activins: from endocrine to paracrine action].
Pigny P; Dewailly D; Racadot A; Boersma A
Ann Endocrinol (Paris); 1996; 57(5):385-94. PubMed ID: 8991102
[TBL] [Abstract][Full Text] [Related]
30. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R
J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339
[TBL] [Abstract][Full Text] [Related]
31. Hope, hypothesis, and the inhibin receptor. Does specific inhibin binding suggest there is a specific inhibin receptor?
Woodruff TK
Endocrinology; 1999 Jan; 140(1):3-5. PubMed ID: 9886799
[No Abstract] [Full Text] [Related]
32. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding.
Krummen LA; Moore A; Woodruff TK; Covello R; Taylor R; Working P; Mather JP
Biol Reprod; 1994 Apr; 50(4):734-44. PubMed ID: 8199254
[TBL] [Abstract][Full Text] [Related]
33. Present status of research on inhibin: an appraisal.
Baker HW; Burger HG; de Kretser DM; Findlay JK; Hudson B; Lee VW; Tsonis CG
Clin Reprod Fertil; 1983 Sep; 2(3):161-74. PubMed ID: 6329502
[No Abstract] [Full Text] [Related]
34. Pituitary binding of 3H-labeled Sertoli cell factor in vitro: a potential radioreceptor assay for inhibin.
Seethalakshmi L; Steinberger A; Steinberger E
Endocrinology; 1984 Oct; 115(4):1289-94. PubMed ID: 6090098
[TBL] [Abstract][Full Text] [Related]
35. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells.
Bilezikjian LM; Blount AL; Campen CA; Gonzalez-Manchon C; Vale W
Mol Endocrinol; 1991 Oct; 5(10):1389-95. PubMed ID: 1663577
[TBL] [Abstract][Full Text] [Related]
36. Inhibin subunits, follistatin and activin receptors in the human teratocarcinoma cell line Tera-2.
de Jong FH; de Winter JP; Wesseling JG; Timmerman MA; van Genesen S; van den Eijnden-van Raaij AJ; van Zoelen EJ
Biochem Biophys Res Commun; 1993 May; 192(3):1334-9. PubMed ID: 8389547
[TBL] [Abstract][Full Text] [Related]
37. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia.
Casagrandi D; Bearfield C; Geary J; Redman CW; Muttukrishna S
Mol Hum Reprod; 2003 Apr; 9(4):199-203. PubMed ID: 12651901
[TBL] [Abstract][Full Text] [Related]
38. Characterization of in vivo phosphorylation of activin type II receptor.
Ichijo H; Yamashita H; ten Dijke P; Eto Y; Heldin CH; Miyazono K
Biochem Biophys Res Commun; 1993 Aug; 194(3):1508-14. PubMed ID: 8394710
[TBL] [Abstract][Full Text] [Related]
39. Expression cloning of an activin receptor, a predicted transmembrane serine kinase.
Mathews LS; Vale WW
Cell; 1991 Jun; 65(6):973-82. PubMed ID: 1646080
[TBL] [Abstract][Full Text] [Related]
40. Inhibin, activin and the female reproductive axis.
Woodruff TK; Mather JP
Annu Rev Physiol; 1995; 57():219-44. PubMed ID: 7778866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
